GlassScriptPhysician profile
Betty Chen
NPI 1750107918
$1,191.49
in general payments reported to CMS, 2019-2025
13 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $22.27 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $454.01 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $314.87 | 2025 | Breztri, Airsupra |
| Lilly USA, LLC | $82.56 | 2025 | Mounjaro, Zepbound, Kisunla |
| Astellas Pharma US INC | $66.15 | 2025 | Veozah |
| Exact Sciences Corporation | $56.25 | 2025 | Cologuard Collection Kit |
| Ars Pharmaceuticals Operations, INC. | $43.23 | 2025 | Neffy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.28 | 2025 | Xifaxan |
| Amgen INC. | $29.82 | 2025 | Repatha, Otezla |
| Abbott Laboratories | $24.67 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $24.24 | 2025 | |
| Medtronic, INC. | $23.35 | 2025 | Intellis Adaptivestim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.42 | 2025 | Jardiance |
| Idorsia Pharmaceuticals US INC | $14.64 | 2025 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betty Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.